Annual CFO
-$106.84 M
-$899.00 K-0.85%
December 31, 2023
Summary
- As of February 26, 2025, CCCC annual cash flow from operations is -$106.84 million, with the most recent change of -$899.00 thousand (-0.85%) on December 31, 2023.
- During the last 3 years, CCCC annual CFO has fallen by -$39.59 million (-58.87%).
- CCCC annual CFO is now -292.11% below its all-time high of $55.61 million, reached on December 31, 2019.
Performance
CCCC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$24.13 M
-$19.16 M-385.18%
September 30, 2024
Summary
- As of February 26, 2025, CCCC quarterly cash flow from operations is -$24.13 million, with the most recent change of -$19.16 million (-385.18%) on September 30, 2024.
- Over the past year, CCCC quarterly CFO has increased by +$6.57 million (+21.41%).
- CCCC quarterly CFO is now -385.18% below its all-time high of -$4.97 million, reached on June 30, 2024.
Performance
CCCC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$71.23 M
+$6.57 M+8.45%
September 30, 2024
Summary
- As of February 26, 2025, CCCC TTM cash flow from operations is -$71.23 million, with the most recent change of +$6.57 million (+8.45%) on September 30, 2024.
- Over the past year, CCCC TTM CFO has increased by +$40.72 million (+36.37%).
- CCCC TTM CFO is now -327.42% below its all-time high of -$16.67 million, reached on March 31, 2020.
Performance
CCCC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CCCC Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.8% | +21.4% | +36.4% |
| 3 y3 years | -58.9% | +21.4% | +36.4% |
| 5 y5 years | -529.2% | +21.4% | +36.4% |
CCCC Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.9% | at low | -385.2% | +27.1% | at high | +36.7% |
| 5 y | 5-year | -292.1% | at low | -385.2% | +27.1% | -327.4% | +36.7% |
| alltime | all time | -292.1% | at low | -385.2% | +27.1% | -327.4% | +36.7% |
C4 Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.13 M(+385.2%) | -$71.23 M(-8.4%) |
| Jun 2024 | - | -$4.97 M(-72.5%) | -$77.81 M(-15.3%) |
| Mar 2024 | - | -$18.12 M(-24.5%) | -$91.83 M(-14.0%) |
| Dec 2023 | -$106.84 M(+0.8%) | -$24.01 M(-21.8%) | -$106.84 M(-4.6%) |
| Sep 2023 | - | -$30.71 M(+61.6%) | -$111.96 M(+2.5%) |
| Jun 2023 | - | -$19.00 M(-42.7%) | -$109.27 M(-2.8%) |
| Mar 2023 | - | -$33.13 M(+13.7%) | -$112.47 M(+6.2%) |
| Dec 2022 | -$105.94 M | -$29.13 M(+4.0%) | -$105.94 M(+3.4%) |
| Sep 2022 | - | -$28.02 M(+26.2%) | -$102.48 M(+10.4%) |
| Jun 2022 | - | -$22.20 M(-16.5%) | -$92.82 M(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$26.60 M(+3.6%) | -$88.63 M(+1.9%) |
| Dec 2021 | -$86.97 M(+29.3%) | -$25.67 M(+39.8%) | -$86.97 M(+4.9%) |
| Sep 2021 | - | -$18.36 M(+2.0%) | -$82.89 M(+5.0%) |
| Jun 2021 | - | -$18.00 M(-27.8%) | -$78.92 M(+4.5%) |
| Mar 2021 | - | -$24.93 M(+15.5%) | -$75.52 M(+12.3%) |
| Dec 2020 | -$67.25 M(-220.9%) | -$21.59 M(+50.0%) | -$67.25 M(+47.3%) |
| Sep 2020 | - | -$14.40 M(-1.4%) | -$45.66 M(+46.1%) |
| Jun 2020 | - | -$14.59 M(-12.4%) | -$31.26 M(+87.6%) |
| Mar 2020 | - | -$16.67 M | -$16.67 M |
| Dec 2019 | $55.61 M(-427.5%) | - | - |
| Dec 2018 | -$16.98 M | - | - |
FAQ
- What is C4 Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for C4 Therapeutics?
- What is C4 Therapeutics annual CFO year-on-year change?
- What is C4 Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for C4 Therapeutics?
- What is C4 Therapeutics quarterly CFO year-on-year change?
- What is C4 Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for C4 Therapeutics?
- What is C4 Therapeutics TTM CFO year-on-year change?
What is C4 Therapeutics annual cash flow from operations?
The current annual CFO of CCCC is -$106.84 M
What is the all time high annual CFO for C4 Therapeutics?
C4 Therapeutics all-time high annual cash flow from operations is $55.61 M
What is C4 Therapeutics annual CFO year-on-year change?
Over the past year, CCCC annual cash flow from operations has changed by -$899.00 K (-0.85%)
What is C4 Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CCCC is -$24.13 M
What is the all time high quarterly CFO for C4 Therapeutics?
C4 Therapeutics all-time high quarterly cash flow from operations is -$4.97 M
What is C4 Therapeutics quarterly CFO year-on-year change?
Over the past year, CCCC quarterly cash flow from operations has changed by +$6.57 M (+21.41%)
What is C4 Therapeutics TTM cash flow from operations?
The current TTM CFO of CCCC is -$71.23 M
What is the all time high TTM CFO for C4 Therapeutics?
C4 Therapeutics all-time high TTM cash flow from operations is -$16.67 M
What is C4 Therapeutics TTM CFO year-on-year change?
Over the past year, CCCC TTM cash flow from operations has changed by +$40.72 M (+36.37%)